Skip to main content

Advertisement

SpringerLink
Log in

The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Primary hyperparathyroidism has been associated with increased incidence of morbidity and mortality of the cardiovascular system. The etiopathogenetic mechanisms underlying this association are still not completely clear. Accumulating evidence suggested that a disintegrin and metalloproteinase with thrombospondin-like motifs (ADAMTS) has a role in the development of inflammation and atherosclerosis. In this study, we aimed to determine whether there is a change in serum levels of ADAMTS1, ADAMTS4, carotid intima-media thickness, and cardiovascular risk score after the surgery and also whether there is a relationship between ADAMTS levels and cardiovascular risk score in hypercalcemic primary hyperparathyroidism patients.

Methods

The study included the 48 consecutive newly diagnosed patients with primary hyperparathyroidism. The patients were evaluated before and six months after parathyroidectomy. The Framingham score is used to calculate cardiovascular risk. Serum ADAMTS levels were determined by a human enzyme-linked immunoassay in all subjects.

Results

The fasting glucose, fasting insulin levels and HOMA values were decreased significantly in all patients after surgery compared to the pretreatment values (p < 0.05). ADAMTS1, ADAMTS4, and carotid intima-media thickness levels were significantly lower after surgical correction of primary hyperparathyroidism compared to the preoperative values (p < 0.05). cardiovascular risk score was decreased after parathyroidectomy however, the difference were not statistical significant (p > 0.05). There were statistically significant relationship between cardiovascular risk score and waist/hip ratio, calcium, LDL-cholesterol, carotid intima-media thickness, ADAMTS4 values.

Conclusion

Based on the results of the present study, fasting glucose, fasting insulin levels, ADAMTS1, ADAMTS4, and carotid intima-media thickness might be an additional parameters during the management of patients with primary hyperparathyroidism, since these factors might improve after surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. S. Ljunghall, H. Lithell, B. Vessby et al., Glucose and lipoprotein metabolism in primary hyperparathyroidism. Effects of parathyroidectomy. Acta. Endocrinol. (Copenh). 89, 580–589 (1978)

    CAS  PubMed  Google Scholar 

  2. M. Procopio, G. Magro, F. Cesario et al., The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed type 2 diabetes mellitus in primary hyperparathyroidism. Diabet. Med. 19, 958–961 (2002)

    Article  CAS  PubMed  Google Scholar 

  3. S. Ljunghall, M. Palmér, G. Å kerström et al., Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur. J. Clin. Invest. 13, 373–377 (1983)

    Article  CAS  PubMed  Google Scholar 

  4. M.J. Bolland, A.B. Grey, G.D. Gamble et al., Association between primary hyperparathyroidism and increased body weight: a metaanalysis. Clin. Endocrinol. Metab. 90, 1525–1530 (2005)

    Article  CAS  Google Scholar 

  5. G. Hedbäck, A. Odén, Death risk factor analysis in primary hyperparathyroidism. Eur. J. Clin. Invest. 28, 1011–1018 (1998)

    Article  Google Scholar 

  6. G. Hedbäck, A. Odén, Increased risk of death from primary hyperparathyroidism – an update. Eur. J. Clin. Invest. 28, 271–276 (1998)

    Article  Google Scholar 

  7. S. Valdemarsson, P. Lindblom, A. Bergenfelz, Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment. J. Intern. Med. 244, 241–249 (1998)

    Article  CAS  PubMed  Google Scholar 

  8. E. Osto, F. Fallo, M.R. Pelizzo et al., Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy. Circulation 126, 1031–1039 (2012)

    Article  PubMed  Google Scholar 

  9. M.D. Walker, S.J. Silverberg, Cardiovascular aspects of primary hyperparathyroidism. J. Endocrinol. Invest. 31, 925–931 (2008)

    Article  CAS  PubMed  Google Scholar 

  10. E. Hagström, E. Lundgren, H. Mallmin et al., Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism. J. Intern. Med. 259, 191–198 (2006)

    Article  Google Scholar 

  11. B. Lacour, J.B. Roullet, A.M. Liagre et al., Serum lipoprotein disturbances in primary and secondary hyperparathyroidism and effects of parathyroidectomy. Am. J. Kidney. Dis. 8, 422–429 (1986)

    Article  CAS  PubMed  Google Scholar 

  12. T. Christensson, K. Einarsson, Serum lipids before and after parathyroidectomy in patients with primary hyperparathyroidism. Clin. Chim. Acta. 78, 411–415 (1977)

    Article  CAS  PubMed  Google Scholar 

  13. S.J. Silverberg, E. Shane, T.P. Jacobs et al., A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N. Engl. J. Med. 341, 1249–1255 (1999)

    Article  CAS  PubMed  Google Scholar 

  14. A. Sitges-Serra, M. Girvent, J.A. Pereira et al., Bone mineral density in menopausal women with primary hyperparathyroidism before and after parathyroidectomy. World J. Surg. 28, 1148–1152 (2004)

    Article  PubMed  Google Scholar 

  15. J. Monchik Normocalcemic hyperparathyroidism. In Textbook of Endocrine Surgery, 424–429 (2005)

  16. R. Stocker, J.F. Keaney Jr., Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381–1478 (2004)

    Article  CAS  PubMed  Google Scholar 

  17. K.J. Williams, I. Tabas, The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15, 551–561 (1995)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. K.J. Williams, Arterial wall chondroitin sulfate proteoglycans: diverse molecules with distinct roles in lipoprotein retention and atherogenesis. Curr. Opin. Lipidol. 12, 477–487 (2001)

    Article  CAS  PubMed  Google Scholar 

  19. T.N. Wight, Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell Biol. 14, 617–623 (2002)

    Article  CAS  PubMed  Google Scholar 

  20. R.C. Salter, T.G. Ashlin, A.P. Kwan et al., ADAMTS proteases: key roles in atherosclerosis? J. Mol. Med. 88, 1203–1211 (2010)

    Article  CAS  PubMed  Google Scholar 

  21. R.D. Kenagy, A.H. Plaas, T.N. Wight, Versican degradation and vascular disease. Trends Cardiovasc. Med. 16, 209–215 (2006)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. S. Porter, I. Clark, L. Keveorkian et al., The ADAMTS metalloproteinases. Biochem. J. 386, 15–27 (2005)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. T. Wight, M. Merrilees, Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ. Res. 94, 1158–1167 (2004)

    Article  CAS  PubMed  Google Scholar 

  24. G. Committee, 2003 European society ve hypertension–European society of cardiology guidelines fort the management of arteriel hypertension. J. Hypertens. 21, 1011–1053 (2003)

    Article  Google Scholar 

  25. D.R. Matthews, J.P. Hosker, A.S. Rudenski et al., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)

    Article  CAS  PubMed  Google Scholar 

  26. E. Orwoll, J.B. Blank, E. Barrett-Connor et al., Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study—a large observational study of the determinants of fracture in older men. Contemp. Clin. Trials 26, 569–585 (2005)

    Article  PubMed  Google Scholar 

  27. R.B. D’Agostino Sr, R.S. Vasan, M.J. Pencina et al., General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117, 743–753 (2008)

    Article  PubMed  Google Scholar 

  28. Z. Galis, G. Sukhova, M. Lark et al., Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94, 2493–2503 (1994)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. L. Chen, L. Yang, Y. Zha et al., Association of serum a disintegrin and metalloproteinase with thrombospodin motif 4 levels with the presence and severity of coronary artery disease. Coron. Artery Dis. 22, 570–576 (2011)

    Article  PubMed  Google Scholar 

  30. Y. Zha, Y. Chen, F. Xu et al., ADAMTS4 level in patients with stable coronary artery disease and acute coronary syndromes. Biomed. Pharmacother. 64, 160–164 (2010)

    Article  CAS  PubMed  Google Scholar 

  31. A. Jönsson-Rylander, T. Nilsson, R. Fritsche-Danielson et al., Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of Versican. Arterioscler. Thromb. Vasc. Biol. 25, 180–185 (2005)

    PubMed  Google Scholar 

  32. S. Kumar, A.O. Olukoga, C. Gordon et al., Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin. Endocrinol. (Oxf). 40, 47–53 (1994)

    Article  CAS  PubMed  Google Scholar 

  33. S. Norenstedt, Y. Pernow, K. Brismar et al., Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind study. Eur. J. Endocrinol. 169, 795–804 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. S.J. Silverberg, B.L. Clarke, M. Peacock et al., Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. Clin. Endocrinol. Metab. 99, 3580–3594 (2014)

    Article  CAS  Google Scholar 

  35. J. Rosa, I. Raska Jr, D. Wichterle et al., Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy. Hypertens. Res. 34, 296–300 (2011)

    Article  PubMed  Google Scholar 

  36. G. Schillaci, G. Pucci, M. Pirro et al., Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis 218, 96–101 (2011)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey

    Melia Karakose, Mustafa Caliskan, Muyesser Sayki Arslan, Taner Demirci & Erman Cakal

  2. Department of Nephrology, Ankara Training and Research Hospital, Ankara, Turkey

    Suleyman Karakose

Authors
  1. Melia Karakose
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mustafa Caliskan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Muyesser Sayki Arslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Taner Demirci
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Suleyman Karakose
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Erman Cakal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Melia Karakose.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karakose, M., Caliskan, M., Arslan, M.S. et al. The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism. Endocrine 55, 283–288 (2017). https://doi.org/10.1007/s12020-016-1175-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-1175-3

Keywords

Search

Navigation